doc. MUDr. Igor Kiss, Ph.D., MBA
Department head, Comprehensive Cancer Care Department
Total number of publications: 245
2016
-
Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma.
Clin Chem Lab Med, year: 2016, volume: 54(12), edition: Dec 1, DOI
-
Anémie u onkologických pacientů
Onkologie v klinické praxi : standardní přístupy v diagnostice a léčbě vybraných zhoubných nádorů, edition: 2. vydání, year: 2016, number of pages: 4 s.
-
BATON-CRC: a phase II randomized trial comparing tivozanib plus mFOLFOX6 with bevacizumab plus mFOLFOX6 in stage IV metastatic colorectal cancer
Journal of Experimental and Clinical Cancer Research, year: 2016, volume: 22/20, edition: Oct 15, DOI
-
Dlouhodobá parciální remise metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii - kazuistika pacienta
Year: 2016
-
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients
Anticancer Research, year: 2016, volume: 36, edition: 9, DOI
-
Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice
Drugs & Aging, year: 2016, volume: 33, edition: 9, DOI
-
Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer
Cancer Genomics & Proteomics, year: 2016, volume: 13, edition: 4
-
Individualizovaná léčba metastatického kolorektálního karcinomu v závislosti na lokalizaci primárního nádoru
Farmakoterapie, year: 2016, volume: 12, edition: 5
-
Nádory pankreatu
Klinická pankreatologie, edition: První vydání, year: 2016, number of pages: 14 s.
-
Serum-Based MicroRNA Signatures in Early Diagnosis and Prognosis Prediction of Colon Cancer
Carcinogenesis, year: 2016, volume: 37, edition: 10, DOI